Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by MrMugsyon May 26, 2022 10:30am
123 Views
Post# 34708943

RE:Hey Mugsy clown

RE:Hey Mugsy clownLook at the Stutters troll - came out from under his rock - with absolutely no insight into the investment he has in ATE.  Hahaha - what investment ?
----------------
You've never said a useful thing about this company - but - clowns will be clowns.


Also, yuour questions/comments are 5th grade - but - I'll entertain them today ...

First ... I have been buying under 70 cents - that's a fact.  Why would you really care?  You should focus on you.

Second ... I'm certainly not buying "every" share nor am I buying "every" day.  Don't think that should really matter to you - should it?  Again, you need to focus on your financial health.

Third ... with respect to how the market is reacting to the shares ... don't care ... I have never put any faith in how a market values a stock.  Sometimes too low and sometimes too high.  That's OK.  This is chess - not weightlifting.

Value - Not Price (write that down on the piece of paper in your back pocket - the one with the lotto numbers you're going to play today).

Now stutters - share some ATE insights that you might have collected since the last time we heard you whine.

Any bets ... I say he's got nothing ?

: )
<< Previous
Bullboard Posts
Next >>